Mozart Therapeutics is a biotech startup focusing on the development of disease-modifying therapies for autoimmune and inflammatory diseases. The company is using a novel regulatory CD8 T cell network to create disease-modifying CD8 Treg modulators for a variety of autoimmune diseases. Mozart is developing a pipeline of first-in-class 'CD8Treg modulators with the goal of restoring long-term immune balance and preventing the progressive damage caused by an autoreactive and pathogenic immune response.

Biotechnology

Mozart Therapeutics

Mozart Therapeutics' headquarters in Seattle, WA, United States

Katie Fanning

Henrijette Richter

Russ Hawkinson

Jennifer More

Kristine Swiderek

Directors Team

Research and Development

Leadership Team

Scientific Advisory Team

Mozart Therapeutics

Org chart

Teams

Directors Team

Research and Development

Leadership Team

Scientific Advisory Team

Offices

Similar companies